Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

Similar articles for PubMed (Select 24213518)

1.

Association of cigarette smoking with the expression of nuclear survivin in pathological Stage IA lung adenocarcinomas.

Hirano H, Maeda H, Takeuchi Y, Susaki Y, Kobayashi R, Hayashi A, Ose N, Nakazawa Y, Yamaguchi T, Yokota S, Mori M.

Med Mol Morphol. 2014 Dec;47(4):196-200. doi: 10.1007/s00795-013-0061-9. Epub 2013 Nov 9.

PMID:
24213518
2.

Nuclear survivin expression in small cell lung cancer.

Yano Y, Otsuka T, Hirano H, Uenami T, Satomi A, Kuroyama M, Niinaka M, Yoneda T, Kimura H, Mori M, Yamaguchi T, Yokota S.

Anticancer Res. 2015 May;35(5):2935-9.

PMID:
25964579
3.

Smoking status impacts microRNA mediated prognosis and lung adenocarcinoma biology.

Vucic EA, Thu KL, Pikor LA, Enfield KS, Yee J, English JC, MacAulay CE, Lam S, Jurisica I, Lam WL.

BMC Cancer. 2014 Oct 24;14:778. doi: 10.1186/1471-2407-14-778.

4.
5.

Nuclear survivin expression in stromal cells of phyllodes tumors and fibroadenomas of the breast.

Hirano H, Matsushita K, Okimura A, Yoshida T, Kizaki T, Ito T.

Anticancer Res. 2014 Mar;34(3):1251-3.

PMID:
24596368
6.

Over-expression of survivin and VEGF in small-cell lung cancer may predict the poorer prognosis.

Chen P, Zhu J, Liu DY, Li HY, Xu N, Hou M.

Med Oncol. 2014 Jan;31(1):775. doi: 10.1007/s12032-013-0775-5. Epub 2013 Dec 15.

PMID:
24338338
7.

Immunohistochemical expression of nuclear and cytoplasmic survivin in gastrointestinal carcinoma.

Shintani M, Sangawa A, Yamao N, Kamoshida S.

Int J Clin Exp Pathol. 2013 Nov 15;6(12):2919-27. eCollection 2013.

8.

EZH2 protein expression associates with the early pathogenesis, tumor progression, and prognosis of non-small cell lung carcinoma.

Behrens C, Solis LM, Lin H, Yuan P, Tang X, Kadara H, Riquelme E, Galindo H, Moran CA, Kalhor N, Swisher SG, Simon GR, Stewart DJ, Lee JJ, Wistuba II.

Clin Cancer Res. 2013 Dec 1;19(23):6556-65. doi: 10.1158/1078-0432.CCR-12-3946. Epub 2013 Oct 4.

9.

Nuclear survivin and its relationship to DNA damage repair genes in non-small cell lung cancer investigated using tissue array.

Hu S, Qu Y, Xu X, Xu Q, Geng J, Xu J.

PLoS One. 2013 Sep 16;8(9):e74161. doi: 10.1371/journal.pone.0074161. eCollection 2013. Erratum in: PLoS One. 2013;8(12). doi:10.1371/annotation/a87d46d5-04ee-4c57-af2b-7b9af5166cd8.

10.

Overexpression of survivin levels in circulation and tissue samples of lung cancer patients.

Kapellos G, Polonifi K, Farmakis D, Spartalis E, Tomos P, Aessopos A, Polizos A, Mantzourani M.

Anticancer Res. 2013 Aug;33(8):3475-80.

PMID:
23898122
11.

The role of p21 Waf1/Cip1 in large airway epithelium in smokers with and without COPD.

Chiappara G, Gjomarkaj M, Virzì A, Sciarrino S, Ferraro M, Bruno A, Montalbano AM, Vitulo P, Minervini MI, Pipitone L, Pace E.

Biochim Biophys Acta. 2013 Oct;1832(10):1473-81. doi: 10.1016/j.bbadis.2013.04.022. Epub 2013 Apr 29.

12.

Survivin expression impacts prognostically on NSCLC but not SCLC.

Rosato A, Menin C, Boldrin D, Dalla Santa S, Bonaldi L, Scaini MC, Del Bianco P, Zardo D, Fassan M, Cappellesso R, Fassina A.

Lung Cancer. 2013 Feb;79(2):180-6. doi: 10.1016/j.lungcan.2012.11.004. Epub 2012 Dec 4.

PMID:
23218791
13.

Survivin expression is associated with lens epithelial cell proliferation and fiber cell differentiation.

Jarrin M, Mansergh FC, Boulton ME, Gunhaga L, Wride MA.

Mol Vis. 2012;18:2758-69. Epub 2012 Nov 22.

14.

Nuclear, but not cytoplasmic, localization of survivin as a negative prognostic factor for survival in upper urinary tract urothelial carcinoma.

Kitamura H, Torigoe T, Hirohashi Y, Asanuma H, Inoue R, Nishida S, Tanaka T, Masumori N, Sato N, Tsukamoto T.

Virchows Arch. 2013 Jan;462(1):101-7. doi: 10.1007/s00428-012-1343-7. Epub 2012 Nov 20.

PMID:
23179762
15.

Tumor islands in resected early-stage lung adenocarcinomas are associated with unique clinicopathologic and molecular characteristics and worse prognosis.

Onozato ML, Kovach AE, Yeap BY, Morales-Oyarvide V, Klepeis VE, Tammireddy S, Heist RS, Mark EJ, Dias-Santagata D, Iafrate AJ, Yagi Y, Mino-Kenudson M.

Am J Surg Pathol. 2013 Feb;37(2):287-94. doi: 10.1097/PAS.0b013e31826885fb.

16.

Relation between smoking history and gene expression profiles in lung adenocarcinomas.

Staaf J, Jönsson G, Jönsson M, Karlsson A, Isaksson S, Salomonsson A, Pettersson HM, Soller M, Ewers SB, Johansson L, Jönsson P, Planck M.

BMC Med Genomics. 2012 Jun 7;5:22.

17.

Prognostic value of survivin expression in Wilms tumor.

Basta-Jovanovic G, Radojevic-Skodric S, Brasanac D, Djuricic S, Milasin J, Bogdanovic L, Opric D, Savin M, Baralic I, Jovanovic M.

J BUON. 2012 Jan-Mar;17(1):168-73.

PMID:
22517713
18.

Correlations of survivin expression with clinicomorphological parameters and hormonal receptor status in breast ductal carcinoma.

Adamkov M, Kajo K, Vybohova D, Krajcovic J, Stuller F, Rajcani J.

Neoplasma. 2012;59(1):30-7.

PMID:
22103896
19.

Prognostic relevance of survivin in pancreatic endocrine tumors.

Ekeblad S, Lejonklou MH, Stålberg P, Skogseid B.

World J Surg. 2012 Jun;36(6):1411-8. doi: 10.1007/s00268-011-1345-7.

20.

Wnt3 gene expression promotes tumor progression in non-small cell lung cancer.

Nakashima N, Liu D, Huang CL, Ueno M, Zhang X, Yokomise H.

Lung Cancer. 2012 May;76(2):228-34. doi: 10.1016/j.lungcan.2011.10.007. Epub 2011 Nov 8.

PMID:
22070884
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk